Only 41% of cancer survivors tested for HIV

Share this content:

the ONA take:

According to a new study published in the journal Preventing Chronic Disease, only 41% of cancer survivors in the United States under the age of 65 reported ever having a human immunodeficiency virus (HIV) test. Patients are typically tested for HIV when they are diagnosed with cancer or their cancer recurs in order to better coordinate cancer and HIV treatment and improve patient outcomes.

Until now, there has been no published data surrounding the proportion of cancer survivors in the United States who are tested for HIV. For the study, researchers analyzed data from the 2009 Behavioral Risk Factor Surveillance System to determine who had been tested for HIV and to identify factors associated with having had HIV testing.

Of the 41% of cancer survivors who had been tested, 72.2% were aged 25 to 34 years, 59.5% were non-Hispanic blacks, and 51.2% were cervical cancer survivors.

The highest proportion of cancer survivors tested for HIV were from Washington, D.C., and the lowest proportion were from Nebraska. Analyses showed cancer survivors were more likely to be tested for HIV if they were non-Hispanic black or Hispanic, younger, educated, not married or living with a partner, not disabled, and concerned about medical costs. Females, but not males, were more likely to be tested if they had an autoimmunodeficiency syndrome (AIDS)-defining illness.

Steroids used for HIV-associated tuberculosis increase cancer risk
Only 41% of cancer survivors in the U.S. under 65 reported ever having a HIV test.
Knowing the human immunodeficiency virus (HIV) serostatus of patients at the time of cancer diagnosis or cancer recurrence is prerequisite to coordinating HIV and cancer treatments and improving treatment outcomes.
READ FULL ARTICLE From Medical News Today
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs